clinical trial · NCT01004263
A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
Organon and Co·phase3·completed·n = 674
Acute Migraine With or Without Aura in Adolescentsrizatriptan benzoate
brief summary
To provide long term safety data for rizatriptan in children and adolescents. The primary hypothesis of the study is that rizatriptan is well tolerated in the long term treatment of acute migraine in pediatric patients age 12-17 years.
started
Dec 1, 2009
primary completion
Apr 18, 2011
completion
Apr 18, 2011
last updated
Apr 22, 2024
official title
A Worldwide, Open Label, Clinical Trial to Examine the Long Term Safety and Tolerability of Rizatriptan in Pediatric Migraineurs for the Treatment of Migraine With or Without Aura
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol